NASDAQ:RXDX
Prometheus Biosciences, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.prometheusbiosciences.comipo date
Mar 12, 2021
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus